02 Sep InVitria
Marcus Curl, VP, Product Applications
Oct. 11 | 11:30am | Rentschler ATMP Ballroom
Junction City, KS
(Private)
InVitria was founded to provide innovative products for the biotechnology industry, improving cell culture, biomanufacturing, and formulation. By eliminating animal components, InVitria enhances consistency, safety, and efficiency in manufacturing processes and drug formulation. Recombinant proteins, excipients, and complete cell culture media are produced by InVitria in Junction City, Kansas. These products find applications in regenerative medicine, cellular therapy, biomanufacturing, vaccines, diagnostics, and medical devices. Traditionally, animal components like fetal bovine serum, human serum, and serum-derived proteins such as albumin, transferrin, insulin, and growth factors have been commonly used. However, these components carry the risk of transmitting prions and viruses, making them undesirable. Additionally, they lack defined properties, leading to significant batch-to-batch variation. Regulatory bodies like the FDA and EMA discourage the use of animal components. InVitria offers recombinant proteins as excipients and media components, along with chemically defined complete cell culture media for optimal performance.
